Circulation, Vol 89, 694-702, Copyright © 1994 by American Heart Association
A Chauhan, PA Mullins, SI Thuraisingham, G Taylor, MC Petch and PM Schofield
BACKGROUND: Although neurostimulation has been shown to be of benefit in
angina pectoris, the exact mechanism of its action is not clear. This study
was performed to examine the effect of transcutaneous electrical nerve
stimulation on coronary blood flow. METHODS AND RESULTS: The effect of
transcutaneous electrical nerve stimulation was studied in 34 syndrome X
patients (group 1), 15 coronary artery disease patients (group 2), and 16
heart transplant patients (group 3). Coronary blood flow velocity (CBFV) in
the left coronary system was measured at rest and after a 5-minute
stimulation period with a Judkins Doppler. There was a significant increase
in the resting CBFV in group 1 (from 6.8 +/- 4.1 to 10.5 +/- 5.7 cm/s, P
< .001) and group 2 (from 6.8 +/- 4.1 to 10.5 +/- 5.7 cm/s, P <
.001). However, there was no significant change in the resting CBFV in
group 3. There were no significant changes in the coronary arterial
diameters as a result of neurostimulation. There was a significant decrease
in the epinephrine levels in group 1 (from 79.6 +/- 17.8 to 58.5 +/- 17.5
ng/L, P = .01) and group 2 (from 102.2 +/- 27.2 to 64.1 +/- 19.1 ng/L, P =
.01). CONCLUSIONS: Transcutaneous electrical nerve stimulation can increase
resting coronary blood flow velocity. The findings suggest that the site of
action is at the microcirculatory level and that the effects may be
mediated by neural mechanisms.
ARTICLES
Effect of transcutaneous electrical nerve stimulation on coronary blood flow
Regional Cardiac Unit, Papworth Hospital, Papworth Everard, Cambrdige, England, UK.
This article has been cited by other articles:
![]() |
A. Phan, C. Shufelt, and C. N. B. Merz Persistent Chest Pain and No Obstructive Coronary Artery Disease JAMA, April 8, 2009; 301(14): 1468 - 1474. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Angelo Sgueglia, A. Sestito, A. Spinelli, B. Cioni, F. Infusino, F. Papacci, F. Bellocci, M. Meglio, F. Crea, and G. Antonio Lanza Long-term follow-up of patients with cardiac syndrome X treated by spinal cord stimulation Heart, May 1, 2007; 93(5): 591 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Moore and M. Chester Neuromodulation for chronic refractory angina Br. Med. Bull., October 1, 2001; 59(1): 269 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Kaski and L. F. Valenzuela Garcia Therapeutic options for the management ofpatients with cardiac syndrome X Eur. Heart J., February 2, 2001; 22(4): 283 - 293. [PDF] |
||||
![]() |
X. Zhou, F. L. Vance IV, A. L. Sims, C. M. Sreenan, and R. E. Ideker Prevention of High Incidence of Neurally Mediated Ventricular Arrhythmias by Afferent Nerve Stimulation in Dogs Circulation, February 22, 2000; 101(7): 819 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Murray, P D Collins, and M A James Neurostimulation treatment for angina pectoris Heart, February 1, 2000; 83(2): 217 - 220. [Full Text] |
||||
![]() |
I A M TenVaarwerk, G A J Jessurun, M J L DeJongste, C Andersen, C Mannheimer, T Eliasson, W Tadema, and M J Staal Clinical outcome of patients treated with spinal cord stimulation for therapeutically refractory angina pectoris Heart, July 1, 1999; 82(1): 82 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Arora, T. M. Chou, D. Jain, B. Fleishman, L. Crawford, T. McKiernan, and R. W. Nesto The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes J. Am. Coll. Cardiol., June 1, 1999; 33(7): 1833 - 1840. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |